Please assess the completion status of the following clinical trial:

Trial Title: Near Infrared Light for the Treatment of Painful Peripheral Neuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults ages 18-85; able to give informed consent~* Documented painful, distal peripheral neuropathy of idiopathic cause, or related to impaired glucose tolerance or diabetes mellitus.~* Neuropathy documented by one of the following studies: nerve conduction studies and needle electromyography (EMG); quantitative sensory testing of the foot with Computer Aided Sensory Evaluator (CASE IV); quantitative sudomotor axon reflex test (Quantitative Sweat MeasurementSystem \[Q-Sweat\]); neurology specialty examination; and neuropathy impairment score (NIS) of less than 25.~* Stable pharmacotherapy for neuropathic pain for at least two weeks.~* Optimal pharmacotherapy has been achieved.~* Subjects cannot be on Cyclooxygenase-2 (COX 2) inhibitors~* Pain Visual Analog Scale (VAS) of greater than or equal to 4/10~* Subject has provided written informed consent~* Not currently using transcutaneous electrical nerve stimulation (TENS)~* Not currently receiving acupuncture~Exclusion Criteria:~* Pregnant or likely to become pregnant~* Current diagnosis of cancer~* Neuropathy impairment score (NIS) of greater than 25.~* Diagnosis of severe neuropathy of known etiology for which specific treatment is available (i.e., acute and chronic inflammatory polyradiculoneuropathies, vasculitis, B 12 deficiency).~* Unstable diabetes mellitus defined as a hemoglobin A1c (HbA1c) greater than 9%, and/or 10% of fasting blood sugars greater than 300 mg/dl for the week prior to enrollment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- MIRE (Type: ACTIVE_COMPARATOR): Subjects randomized to this arm will receive treatment with monochromatic near infrared photo energy (MIRE).
- Sham (Type: SHAM_COMPARATOR): Subjects randomized to this arm will receive treatment with the sham device, which is non-active but otherwise identical to the study device.

Based on this trial design, predict the completion outcome and termination type (if applicable).